Three patients developed hepatic toxicity (maximum of grade 3 in two patients) with elevated glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT), and two patients developed thrombocytopenia (maximum of grade 4). This evidence concerns the gene GPT and Thrombocytopenia.